| |
| Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study |
| Ghosh S, Choudhary NS, Sharma AK, Singh B, Kumar P, Agarwal R, Sharma N, Bhalla A, Chawla YK, Singh V |
|
|
| |
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Ghosh S, Choudhary NS, Sharma AK, Singh B, Kumar P, Agarwal R, Sharma N, Bhalla A, Chawla YK, Singh V. Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study. Liver International 2013; 33(8): 1187-1193 Indexing Status Subject indexing assigned by NLM MeSH Adult; Biomarkers /blood /urine; Chi-Square Distribution; Creatinine /blood; Female; Hemodynamics /drug effects; Hepatorenal Syndrome /diagnosis /drug therapy /metabolism /physiopathology; Humans; India; Kaplan-Meier Estimate; Logistic Models; Lypressin /adverse effects /analogs & Male; Middle Aged; Multivariate Analysis; Norepinephrine /adverse effects /therapeutic use; Pilot Projects; Sodium /urine; Tertiary Care Centers; Time Factors; Treatment Outcome; Urination; Vasoconstrictor Agents /adverse effects /therapeutic use; derivatives /therapeutic use AccessionNumber 22013040403 Date bibliographic record published 23/10/2013 |
| |
|
|
